Jarasch N - Search Results

1

Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.

Henke A, Jarasch N, Martin U, Zell R, Wutzler P. Henke A, et al. Among authors: jarasch n. Viral Immunol. 2008 Mar;21(1):38-48. doi: 10.1089/vim.2007.0077. Viral Immunol. 2008. PMID: 18355121

2

Vaccination procedures against Coxsackievirus-induced heart disease.

Henke A, Jarasch N, Wutzler P. Henke A, et al. Among authors: jarasch n. Expert Rev Vaccines. 2003 Dec;2(6):805-15. doi: 10.1586/14760584.2.6.805. Expert Rev Vaccines. 2003. PMID: 14711363 Free article. Review.

3

Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.

Jarasch N, Martin U, Kamphausen E, Zell R, Wutzler P, Henke A. Jarasch N, et al. Viral Immunol. 2005;18(2):355-64. doi: 10.1089/vim.2005.18.355. Viral Immunol. 2005. PMID: 16035947

4

Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.

Martin U, Jarasch N, Nestler M, Rassmann A, Munder T, Seitz S, Zell R, Wutzler P, Henke A. Martin U, et al. Among authors: jarasch n. Apoptosis. 2007 Mar;12(3):525-33. doi: 10.1007/s10495-006-0015-y. Epub 2007 Jan 9. Apoptosis. 2007. PMID: 17211569

5

Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes.

Jarasch N, Martin U, Zell R, Wutzler P, Henke A. Jarasch N, et al. Apoptosis. 2007 Sep;12(9):1633-43. doi: 10.1007/s10495-007-0084-6. Apoptosis. 2007. PMID: 17520192

6

Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.

Henke A, Jarasch N, Martin U, Wegert J, Wildner A, Zell R, Wutzler P. Henke A, et al. Among authors: jarasch n. Int J Med Microbiol. 2008 Jan;298(1-2):127-34. doi: 10.1016/j.ijmm.2007.08.010. Epub 2007 Sep 25. Int J Med Microbiol. 2008. PMID: 17897883 Review.

7

Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.

Henke A, Jarasch N, Wutzler P. Henke A, et al. Among authors: jarasch n. Expert Rev Vaccines. 2008 Dec;7(10):1557-67. doi: 10.1586/14760584.7.10.1557. Expert Rev Vaccines. 2008. PMID: 19053211 Free article. Review.

8

The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases?

Rassmann A, Henke A, Jarasch N, Lottspeich F, Saluz HP, Munder T. Rassmann A, et al. Among authors: jarasch n. Antiviral Res. 2007 Nov;76(2):150-8. doi: 10.1016/j.antiviral.2007.06.011. Epub 2007 Jul 16. Antiviral Res. 2007. PMID: 17662476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters